At a glance
- Originator Yamanouchi
- Class Anti-ischaemics
- Mechanism of Action Calcium channel agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Myocardial infarction
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Myocardial infarction in Japan (Unknown route)
- 15 Feb 1996 New profile
- 15 Feb 1996 Preclinical development for Myocardial infarction in Japan (Unknown route)